JPWO2009084742A1 - 線維芽細胞増殖剤 - Google Patents
線維芽細胞増殖剤 Download PDFInfo
- Publication number
- JPWO2009084742A1 JPWO2009084742A1 JP2009548134A JP2009548134A JPWO2009084742A1 JP WO2009084742 A1 JPWO2009084742 A1 JP WO2009084742A1 JP 2009548134 A JP2009548134 A JP 2009548134A JP 2009548134 A JP2009548134 A JP 2009548134A JP WO2009084742 A1 JPWO2009084742 A1 JP WO2009084742A1
- Authority
- JP
- Japan
- Prior art keywords
- extract
- fibroblast
- yeast
- skin
- aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000002950 fibroblast Anatomy 0.000 title claims abstract description 61
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 37
- 239000012138 yeast extract Substances 0.000 claims abstract description 37
- 229940119485 safflower extract Drugs 0.000 claims abstract description 29
- 230000002062 proliferating effect Effects 0.000 claims abstract description 16
- 230000035755 proliferation Effects 0.000 claims abstract description 11
- 239000004480 active ingredient Substances 0.000 claims abstract description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 24
- 230000032683 aging Effects 0.000 claims description 23
- 238000002360 preparation method Methods 0.000 claims description 20
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 16
- 239000002537 cosmetic Substances 0.000 claims description 12
- 238000011282 treatment Methods 0.000 claims description 9
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 8
- 235000015097 nutrients Nutrition 0.000 claims description 8
- 230000003712 anti-aging effect Effects 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 230000002500 effect on skin Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 30
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 21
- 238000000605 extraction Methods 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- -1 foundations Substances 0.000 description 10
- 230000012010 growth Effects 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 239000002904 solvent Substances 0.000 description 9
- 244000020518 Carthamus tinctorius Species 0.000 description 8
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 8
- 239000006071 cream Substances 0.000 description 8
- 210000004207 dermis Anatomy 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 239000006210 lotion Substances 0.000 description 7
- 230000009759 skin aging Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 210000002808 connective tissue Anatomy 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000007665 sagging Methods 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 241001465321 Eremothecium Species 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 3
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 3
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- NDHNBHXAALUAAJ-UHFFFAOYSA-N 4,5-dimorpholin-4-yl-1h-pyridazin-6-one Chemical compound C1COCCN1C=1C(O)=NN=CC=1N1CCOCC1 NDHNBHXAALUAAJ-UHFFFAOYSA-N 0.000 description 2
- 208000035404 Autolysis Diseases 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- 206010057248 Cell death Diseases 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241000235035 Debaryomyces Species 0.000 description 2
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 2
- GTAXGNCCEYZRII-UHFFFAOYSA-N Eperisone hydrochloride Chemical compound Cl.C1=CC(CC)=CC=C1C(=O)C(C)CN1CCCCC1 GTAXGNCCEYZRII-UHFFFAOYSA-N 0.000 description 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241001529734 Ocimum Species 0.000 description 2
- 235000011205 Ocimum Nutrition 0.000 description 2
- 244000136948 Ocimum sanctum Species 0.000 description 2
- 235000004072 Ocimum sanctum Nutrition 0.000 description 2
- 241000235648 Pichia Species 0.000 description 2
- 241001489223 Saccharomycodes Species 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 230000020411 cell activation Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 229940072117 fennel extract Drugs 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000003495 polar organic solvent Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000028043 self proteolysis Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 229960005066 trisodium edetate Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- GAOFSPAZESJCOA-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1.OCCOC1=CC=CC=C1 GAOFSPAZESJCOA-UHFFFAOYSA-N 0.000 description 1
- UAXUIYBGZNXVCN-UHFFFAOYSA-N 3-silylpropylcarbamic acid Chemical compound [SiH3]CCCNC(O)=O UAXUIYBGZNXVCN-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241000722885 Brettanomyces Species 0.000 description 1
- 241000167550 Centella Species 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 241001508787 Citeromyces Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000178951 Endomyces Species 0.000 description 1
- 241001542272 Endomycetaceae Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000235167 Eremascus Species 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001149669 Hanseniaspora Species 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- 240000004322 Lens culinaris Species 0.000 description 1
- 244000043158 Lens esculenta Species 0.000 description 1
- 235000010666 Lens esculenta Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241001149698 Lipomyces Species 0.000 description 1
- 241001508815 Lodderomyces Species 0.000 description 1
- 235000019510 Long pepper Nutrition 0.000 description 1
- 241001123674 Metschnikowia Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000193596 Nadsonia Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000235652 Pachysolen Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000003455 Piper longum Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 244000128206 Pyracantha coccinea Species 0.000 description 1
- 235000003105 Pyracantha coccinea Nutrition 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000235344 Saccharomycetaceae Species 0.000 description 1
- 241000235003 Saccharomycopsis Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 241000311088 Schwanniomyces Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241000193620 Wickerhamia Species 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000012996 alamarblue reagent Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- WSWYZRBSUBMICN-UHFFFAOYSA-N azanium;2-(dimethylamino)-3-oxopent-4-ene-1-sulfonate Chemical compound [NH4+].[O-]S(=O)(=O)CC(N(C)C)C(=O)C=C WSWYZRBSUBMICN-UHFFFAOYSA-N 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- LFSBSHDDAGNCTM-UHFFFAOYSA-N cobalt(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Co+2] LFSBSHDDAGNCTM-UHFFFAOYSA-N 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001120 cytoprotective effect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000550 effect on aging Effects 0.000 description 1
- 230000002849 elastaseinhibitory effect Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000001651 pyrus cydonia seed extract Substances 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 229940047670 sodium acrylate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
sanctum, Ocimum tenuiflorum, Ocimum album)などの植物の抽出物やハイビスカス抽出物などが線維芽細胞増殖活性を有し、それら物質を老化防止化粧料等に配合することが報告されている。
Personal Care Products L.P.社から「バイオダインEMPP(商標)」の商品名で市販されている。
「若い細胞」としてヒト新生児包皮由来の線維芽細胞を、「加齢細胞」として70代女性皮膚真皮由来の線維芽細胞を用いた。
(1)ジメチルポリシロキサン 3.0
(2)デカメチルシクロペンタシロキサン 13.0
(3)ドデカメチルシクロヘキサシロキサン 5.0
(4)ポリオキシエチレン・メチルポリシロキサン共重合体 1.0
(5)3−トリス(トリメチルシロキシ) 1.0
シリルプロピルカルバミド酸プルラン
(6)架橋型ポリメチルシロキサンの
デカメチルシクロペンタシロキサン配合物 5.0
(Dow Corning 9040 Silicone Elastomer BlendTM:Dow Corning社製)
(7)酢酸レチノール 0.1
(8)パラオキシ安息香酸エステル 適量
(9)L−メントール 適量
(10)トリメチルシロキシケイ酸 2.0
(11)エタノール 2.0
(12)グリセリン 3.0
(13)ジプロピレングリコール 5.0
(14)ポリエチレングリコール6000 5.0
(15)ヘキサメタリン酸ナトリウム 0.05
(16)酢酸トコフェロール 0.1
(17)カフェイン 0.1
(18)ウイキョウエキス 0.1
(19)ハマメリスエキス 0.1
(20)ベニバナエキス 1.0
(21)酵母エキス 1.0
(22)エデト酸三ナトリウム 0.05
(23)ジモルホリノピリダジノン 0.01
(24)トリメトキシ桂皮酸メチルビス 0.1
(トリメチルシロキシ)シリルイソペンチル
(25)無機複合粉体 5.0
(カバーリーフAR−80TM;触媒化成工業(株)製)
(26)黄酸化鉄 適量
(27)チタン酸コバルト 適量
(28)ジメチルジステアリルアンモニウムヘクトライト 1.5
(29)ポリビニルアルコール 0.1
(30)ヒドロキシエチルセルロース 0.1
(31)アクリル酸ナトリウム/2−アクリルアミド−2−メチルプロパン
スルホン酸共重合体(SIMULGEL EGTM;SEPPIC社製) 0.1
(32)(アクロイルジメチルタウリンアンモニウム/VP)コポリマー
(Aristoflex AVCTM;Clariant社製) 0.1
(33)香料 適量
(34)精製水 残余
ワセリン 5
ベヘニルアルコール 0.5
バチルアルコール 0.5
グリセリン 7
1,3−ブチレングリコール 7
1,2−ペンタンジオール 1
キシリット 3
ポリエチレングリコール20000 2
硬化油 2
ホホバ油 2
スクワラン 5
イソステアリン酸 0.5
テトラ2−エチルヘキサン酸ペンタエリスリット 2
ポリオキシエチレン硬化ヒマシ油 0.5
ラウリルジメチルアミノ酢酸ベタイン 0.4
水酸化カリウム 適量
ピロ亜硫酸ナトリウム 0.01
ヘキサメタリン酸ナトリウム 0.05
グリチルリチン酸ジカリウム 0.05
トリメチルグリシン 3
アルブチン 3
酵母エキス 0.1
酢酸トコフェロール 0.1
チオタウリン 0.1
ベニバナエキス 1
クララエキス 0.1
ベンガラ 適量
クインスシードエキス 0.1
カルボキシビニルポリマー 0.2
フェノキシエタノール 適量
精製水 残余
ジメチルポリシロキサン 3
デカメチルシクロペンタシロキサン 4
エタノール 5
グリセリン 6
1,3−ブチレングリコール 5
ポリオキシエチレンメチルグルコシド 3
ヒマワリ油 1
スクワラン 2
水酸化カリウム 0.1
ヘキサメタリン酸ナトリウム 0.05
ヒドロキシプロピル−β−シクロデキストリン 0.1
グリチルリチン酸ジカリウム 0.05
ビワ葉エキス 0.1
L−グルタミン酸ナトリウム 0.05
ウイキョウエキス 0.1
酵母エキス 0.1
ラベンダー油 0.1
ベニバナエキス 0.1
ジオウエキス 0.1
ジモルホリノピリダジノン 0.1
キサンタンガム 0.1
カルボキシビニルポリマー 0.1
アクリル酸・メタクリル酸アルキル共重合体 0.1
(ペミュレンTR−1)
ベンガラ 適量
黄酸化鉄 適量
パラベン 適量
精製水 残余
Claims (9)
- 酵母エキスとベニバナエキスとを有効成分として含む線維芽細胞増殖剤。
- 前記酵母エキスが、グリコサミノグリカンを含有する栄養培地中で培養されかつ紫外線照射、過酸化水素処理またはそれら両方の処理を受けた酵母から調製されたものである請求項1記載の線維芽細胞増殖剤。
- 前記線維芽細胞が加齢線維芽細胞である請求項1または2記載の線維芽細胞増殖剤。
- 請求項1から3いずれか1項記載の線維芽細胞増殖剤を含有する皮膚外用剤。
- 化粧料である請求項4記載の皮膚外用剤。
- 酵母エキスおよびベニバナエキスを用いて線維芽細胞を増殖させる方法。
- 前記酵母エキスが、グリコサミノグリカンを含有する栄養培地中で培養されかつ紫外線照射、過酸化水素処理またはそれら両方の処理を受けた酵母から調製されたものである請求項6記載の方法。
- 前記線維芽細胞が加齢線維芽細胞である請求項6記載の方法。
- 酵母エキスとベニバナエキスとを有効成分として含む皮膚老化防止剤。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2009/001447 WO2009084742A2 (ja) | 2009-03-30 | 2009-03-30 | 線維芽細胞増殖剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2009084742A1 true JPWO2009084742A1 (ja) | 2012-04-05 |
JP5468906B2 JP5468906B2 (ja) | 2014-04-09 |
Family
ID=40824856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009548134A Active JP5468906B2 (ja) | 2009-03-30 | 2009-03-30 | 線維芽細胞増殖剤 |
Country Status (8)
Country | Link |
---|---|
US (2) | US20100316664A1 (ja) |
EP (1) | EP2110123B1 (ja) |
JP (1) | JP5468906B2 (ja) |
KR (1) | KR101632265B1 (ja) |
CN (1) | CN101795668B (ja) |
ES (1) | ES2569607T3 (ja) |
RU (1) | RU2492850C2 (ja) |
WO (1) | WO2009084742A2 (ja) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2976490B1 (fr) * | 2011-06-20 | 2013-07-12 | Silab Sa | Utilisation de substances agissant sur l'igf-1 et/ou l'igf-1r pour leur activite anti-age |
EP2540170A1 (de) * | 2011-06-29 | 2013-01-02 | Evonik Degussa GmbH | Dermatologisch wirksamer Hefeextrakt |
US8795640B2 (en) | 2011-12-22 | 2014-08-05 | Mary Kay Inc. | Lip formulation |
KR101420211B1 (ko) * | 2012-07-03 | 2014-07-17 | (주)바이오시엠 | 새싹추출물 및 새순추출물을 이용한 피부 외용제 조성물 |
US10543240B2 (en) | 2016-12-12 | 2020-01-28 | Johnson & Johnson Consumer Inc. | Topical composition containing glycerin and yeast extract |
US11241465B2 (en) | 2017-03-20 | 2022-02-08 | Es Biosolutions, Inc. | Compositions and methods for skin treatments |
JP7241483B2 (ja) * | 2018-07-23 | 2023-03-17 | 株式会社ノエビア | 皮膚用組成物 |
US11166997B2 (en) | 2018-07-27 | 2021-11-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
EP3829610A1 (en) | 2018-07-27 | 2021-06-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
WO2020021481A1 (en) | 2018-07-27 | 2020-01-30 | Johnson & Johnson Vision Care, Inc. | Compositions and methods for treating the eye |
US11110051B2 (en) | 2018-08-30 | 2021-09-07 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and n-acetyl glucosamine |
US11045416B2 (en) | 2018-08-30 | 2021-06-29 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and retinol |
JP7259157B2 (ja) * | 2018-11-05 | 2023-04-18 | 共栄化学工業株式会社 | 皮膚外用剤 |
US11969451B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
CN111588656B (zh) * | 2020-04-30 | 2021-09-14 | 杭州谦美化妆品有限公司 | 一种水解假丝酵母和日本清酒酵母共生发酵产物的用途 |
JP7225459B1 (ja) | 2022-06-01 | 2023-02-20 | 株式会社 資生堂 | シュワン細胞のアンギオポエチン1(Ang-1)分泌を促進するための、ベニバナエキスを含んでなる、組成物 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4803800A (en) * | 1987-03-27 | 1989-02-14 | Plant Genetics, Inc. | Synthetic substrate for filamentous fungi |
FR2690352B1 (fr) | 1992-04-27 | 1994-06-10 | Marandel Jean Bernard | Patin a roulettes a platine inclinee. |
JP3213189B2 (ja) | 1994-12-15 | 2001-10-02 | カネボウ株式会社 | ヒアルロン酸産生促進剤 |
JP3748941B2 (ja) | 1996-05-01 | 2006-02-22 | 株式会社ナリス化粧品 | 老化防止化粧料 |
US6207694B1 (en) * | 1998-07-27 | 2001-03-27 | Howard Murad | Pharmaceutical compositions and methods for managing scalp conditions |
JP3432175B2 (ja) * | 1999-04-30 | 2003-08-04 | 善三郎 原 | 細胞増殖促進化粧料 |
JP3839618B2 (ja) | 1999-05-13 | 2006-11-01 | 株式会社ノエビア | エラスターゼ阻害剤、及びこれを含有して成る老化防止用皮膚外用剤 |
US6461857B1 (en) * | 2000-07-19 | 2002-10-08 | Arch Personal Care Products, L.P. | Producing water-soluble yeast extract by adding peroxide to growing yeast cells |
FR2819414A1 (fr) * | 2001-01-15 | 2002-07-19 | Cognis France Sa | Preparations cosmetiques et/ou pharmaceutiques comprenant des extraits de plantes dites a resurrection |
JP3641699B2 (ja) | 2001-05-29 | 2005-04-27 | 株式会社ノエビア | 皮膚外用剤 |
JP2003137763A (ja) * | 2001-11-01 | 2003-05-14 | Noevir Co Ltd | 皮膚外用剤 |
JP2003342124A (ja) * | 2002-05-31 | 2003-12-03 | Noevir Co Ltd | 皮膚外用剤 |
KR100670237B1 (ko) * | 2003-11-13 | 2007-01-17 | 주식회사 사임당화장품 | 홍화씨추출물을 함유하는 화장료 조성물 및 홍화씨 내 화장료 유효성분 추출방법 |
JP3839438B2 (ja) | 2004-02-17 | 2006-11-01 | 徳雄 陳 | アトピー性疾患予防・治療剤 |
CN1921823A (zh) | 2004-03-11 | 2007-02-28 | 株式会社资生堂 | 抗老化剂和胶原产生促进剂 |
KR100803924B1 (ko) * | 2005-12-22 | 2008-02-15 | 주식회사 코리아나화장품 | 토마토, 포도, 홍화씨 혼합 초임계 유체 추출물을유효성분으로 함유하는 피부노화 방지용 화장료 조성물 |
JP2007210915A (ja) * | 2006-02-08 | 2007-08-23 | Kose Corp | 皮膚外用剤 |
JP2008184441A (ja) | 2007-01-30 | 2008-08-14 | B & C Laboratories Inc | 細胞増殖促進用皮膚外用剤 |
KR101437939B1 (ko) * | 2007-04-20 | 2014-11-03 | 주식회사 엘지생활건강 | 주름개선용 화장료 조성물 |
WO2008151260A2 (en) * | 2007-06-04 | 2008-12-11 | Farr Laboratories, Llc | Skin care method and kit using peltier thermoelectric device |
KR100937339B1 (ko) * | 2007-07-20 | 2010-01-20 | 주식회사 코리아나화장품 | 동백꽃, 금은화, 이화, 회화, 백련화, 홍화 및 매화의 혼합 추출물로 구성된 칠화수를 포함하는 피부노화 방지용 화장료 조성물 |
-
2009
- 2009-03-30 JP JP2009548134A patent/JP5468906B2/ja active Active
- 2009-03-30 EP EP09700092.1A patent/EP2110123B1/en active Active
- 2009-03-30 KR KR1020107018340A patent/KR101632265B1/ko active IP Right Grant
- 2009-03-30 ES ES09700092.1T patent/ES2569607T3/es active Active
- 2009-03-30 RU RU2009128650/15A patent/RU2492850C2/ru not_active IP Right Cessation
- 2009-03-30 WO PCT/JP2009/001447 patent/WO2009084742A2/ja active Application Filing
- 2009-03-30 US US12/867,771 patent/US20100316664A1/en not_active Abandoned
- 2009-03-30 CN CN200980000086.5A patent/CN101795668B/zh active Active
-
2012
- 2012-08-24 US US13/593,683 patent/US8628783B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2009084742A3 (ja) | 2009-08-27 |
RU2492850C2 (ru) | 2013-09-20 |
US8628783B2 (en) | 2014-01-14 |
CN101795668A (zh) | 2010-08-04 |
WO2009084742A2 (ja) | 2009-07-09 |
JP5468906B2 (ja) | 2014-04-09 |
US20100316664A1 (en) | 2010-12-16 |
RU2009128650A (ru) | 2011-01-27 |
ES2569607T3 (es) | 2016-05-11 |
KR101632265B1 (ko) | 2016-06-21 |
EP2110123A2 (en) | 2009-10-21 |
EP2110123A4 (en) | 2012-08-01 |
EP2110123B1 (en) | 2016-03-23 |
US20120328648A1 (en) | 2012-12-27 |
CN101795668B (zh) | 2014-11-05 |
KR20120041090A (ko) | 2012-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5468906B2 (ja) | 線維芽細胞増殖剤 | |
CA2749750C (en) | Skin care compositions and methods of use thereof | |
WO2021017846A1 (zh) | 增强的抗衰老化妆品组合物 | |
KR101884411B1 (ko) | 미백 및 보습용 기능성 화장료 조성물 | |
JPWO2004016236A1 (ja) | 化粧料 | |
KR101275971B1 (ko) | 항산화 활성을 가지는 꽃송이버섯 발효 추출물 및 이를 함유하는 화장료 조성물 | |
KR20140024840A (ko) | 피부, 점막, 모발 및/또는 손발톱의 치료 및/또는 관리를 위한 엑소폴리사카라이드 | |
KR20100132511A (ko) | 주름을 방지 또는 개선하기 위한 경구, 주사, 피부 외용제 및 미용 방법 | |
TW201206494A (en) | Use of Tiliacora triandra in cosmetics and compositions thereof | |
KR20070006772A (ko) | 항노화제 및 콜라겐 생성 촉진제 | |
JP2023171950A (ja) | 抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料 | |
JP2016027034A (ja) | 外用組成物 | |
US20170281500A1 (en) | Vegfc production promoter | |
JP2004107243A (ja) | シワ及び/又はたるみ改善用キット | |
KR20150137692A (ko) | 홍설차 추출물을 포함하는 화장료 조성물 | |
TWI457144B (zh) | Fibroblast proliferator | |
JP2009234976A (ja) | 細胞賦活剤、及び老化防止用皮膚外用剤 | |
JP2009249366A (ja) | コラーゲン産生促進剤、及び老化防止用皮膚外用剤 | |
KR20160020038A (ko) | 프랜지패니 오일 또는 프랜지패니 오일의 발효물을 포함하는 화장료 조성물 | |
KR102666496B1 (ko) | 피부미백, 피부진정 및 피부주름 개선용 화장료 조성물 | |
JP5937465B2 (ja) | コラーゲン産生促進剤、線維芽細胞増殖促進剤、しわ改善剤および皮膚外用剤 | |
EP4438028A1 (en) | Porous silica impregnated with epidermidibacterium keratini extract and use thereof for improving skin condition | |
JP7411196B2 (ja) | Xvii型コラーゲン維持強化剤 | |
JP6803113B2 (ja) | 評価方法及び皮膚外用剤 | |
JP2024055621A (ja) | 皮膚恒常性維持外用剤、これを含む化粧品、医薬品、及び医薬部外品、並びに、皮膚恒常性維持方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111226 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130625 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130823 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140128 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140130 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5468906 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |